In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice

[1]  M. Mattson,et al.  Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice , 2007, NeuroMolecular Medicine.

[2]  Jochen Herms,et al.  Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members , 2004 .

[3]  T. Bayer,et al.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. , 2004, The American journal of pathology.

[4]  C. Cotman,et al.  Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging - eScholarship , 2004 .

[5]  Edward A. Stern,et al.  Cortical Synaptic Integration In Vivo Is Disrupted by Amyloid-β Plaques , 2004, The Journal of Neuroscience.

[6]  H. Steinbusch,et al.  Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. , 2004, The American journal of pathology.

[7]  Sheng-Kwei Song,et al.  Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition , 2004, Neurobiology of Disease.

[8]  Brian J Bacskai,et al.  Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  M. Dhenain,et al.  Regional atrophy in the brain of lissencephalic mouse lemur primates: Measurement by automatic histogram‐based segmentation of MR images , 2003, Magnetic resonance in medicine.

[10]  T. Bayer,et al.  Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.

[11]  G. Higgins,et al.  Transgenic mouse models of Alzheimer's disease: phenotype and application , 2003, Behavioural pharmacology.

[12]  J. Konsman.  The mouse brain in stereotaxic coordinates Second Edition (Deluxe) By Paxinos G. and Franklin, K.B.J., Academic Press, New York, 2001, ISBN 0-12-547637-X , 2003, Psychoneuroendocrinology.

[13]  R. Williams,et al.  Genetic architecture of the mouse hippocampus: identification of gene loci with selective regional effects , 2003, Genes, brain, and behavior.

[14]  Thomas Wisniewski,et al.  Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.

[15]  Russell E Jacobs,et al.  Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Valk.  Magnetic Resonance in Dementia , 2004 .

[17]  L. Li,et al.  Impaired Eyeblink Conditioning and Decreased Hippocampal Volume in PDAPP V717F Mice , 2002, Neurobiology of Disease.

[18]  K. Unsicker,et al.  Morphological alterations in the amygdala and hippocampus of mice during ageing , 2002, The European journal of neuroscience.

[19]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[20]  B. Hyman,et al.  Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy‐X04, a Systemically Administered Congo Red Derivative , 2002, Journal of neuropathology and experimental neurology.

[21]  B. de Strooper,et al.  Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease. , 2002, Trends in pharmacological sciences.

[22]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[23]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[24]  B. Sommer.  Alzheimer's disease and the amyloid cascade hypothesis: ten years on. , 2002, Current opinion in pharmacology.

[25]  Harald Hampel,et al.  Progression of corpus callosum atrophy in Alzheimer disease. , 2002, Archives of neurology.

[26]  PhD Jaap Valk MD,et al.  Magnetic Resonance in Dementia , 2002, Springer Berlin Heidelberg.

[27]  T. Bayer,et al.  Reelin in plaques of β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[28]  S. Black,et al.  Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD , 2001 .

[29]  K. Ashe.  Learning and memory in transgenic mice modeling Alzheimer's disease. , 2001, Learning & memory.

[30]  T. Aosaki,et al.  Deficiency of presenilin‐1 increases calcium‐dependent vulnerability of neurons to oxidative stress in vitro , 2001, Journal of neurochemistry.

[31]  F. Gonzalez-Lima,et al.  Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease , 2001, Neuroreport.

[32]  D. Westaway,et al.  Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.

[33]  Oliver Wirths,et al.  Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[34]  F. Bian,et al.  Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.

[35]  T. Bayer,et al.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. , 2001, Neuroscience letters.

[36]  B. Hyman,et al.  Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. , 2000, The American journal of pathology.

[37]  S. Paul,et al.  Neuroanatomical Abnormalities in Behaviorally Characterized APPV717F Transgenic Mice , 2000, Neurobiology of Disease.

[38]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[39]  C. Duyckaerts,et al.  MRI description of cerebral atrophy in mouse lemur primates , 2000, Neurobiology of Aging.

[40]  F. van Leuven.  Single and multiple transgenic mice as models for Alzheimer's disease. , 2000, Progress in neurobiology.

[41]  H. Lipp,et al.  Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P Pietrini,et al.  Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. , 1999, Archives of neurology.

[43]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.

[44]  H. Braak,et al.  The Progression of Alzheimer’s Disease from Limbic Regions to the Neocortex: Clinical, Radiological and Pathological Relationships , 1999, Dementia and Geriatric Cognitive Disorders.

[45]  C. Masters,et al.  Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. , 1999, Journal of Alzheimer's disease : JAD.

[46]  K. Jellinger,et al.  Neuropathology of Alzheimer's disease: a critical update. , 1998, Journal of neural transmission. Supplementum.

[47]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[48]  J. Wegiel,et al.  Neurofibrillary pathology — correlation with hippocampal formation atrophy in Alzheimer disease , 1996, Neurobiology of Aging.

[49]  U Klose,et al.  Reliability and exactness of MRI‐based volumetry: A phantom study , 1996, Journal of magnetic resonance imaging : JMRI.

[50]  A. Smith,et al.  Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.

[51]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[52]  D. Selkoe,et al.  Cell-surface beta-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[54]  E. Wenger,et al.  Morphometric analysis of the corpus callosum using MR: correlation of measurements with aging in healthy individuals. , 1993, AJNR. American journal of neuroradiology.

[55]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[56]  K. Krishnan,et al.  Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. , 1992, AJNR. American journal of neuroradiology.

[57]  Mustafa M. Husain,et al.  Assessment of posterior fossa structures with midsagittal MRI: The effects of age , 1991, Neurobiology of Aging.

[58]  Glenn D. Rosen,et al.  Brain volume estimation from serial section measurements: a comparison of methodologies , 1990, Journal of Neuroscience Methods.

[59]  L. Axel,et al.  Intensity correction in surface-coil MR imaging. , 1987, AJR. American journal of roentgenology.

[60]  R. Regan,et al.  DETECTION OF , 2012 .

[61]  H. Puchtler,et al.  ON THE BINDING OF CONGO RED BY AMYLOID , 1962 .